Is elevated noradrenaline an aetiological factor in a number of diseases?

Autonomic and Autacoid Pharmacology

Volumn 29, Issue 4, 2009, Pages 143-156

  Fitzgerald, P J ^a,b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clonidine; Noradrenaline; Pharmacology; Propranolol; Tricyclic antidepressant

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CARVEDILOL; CLONIDINE; DESIPRAMINE; FADOLMIDINE; FLUOXETINE; IMIPRAMINE; INSULIN; NADOLOL; NORADRENALIN; NORTRIPTYLINE; PLACEBO; PROPRANOLOL; SALMETEROL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIMOLOL; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNCLASSIFIED DRUG; XYLAZINE; YOHIMBINE;

ADRENERGIC SYSTEM; ARTHRITIS; ASTHMA; BIPOLAR DISORDER; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DISEASE PREDISPOSITION; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OPEN ANGLE GLAUCOMA; OSTEOARTHRITIS; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; ASTHMA; DIABETES MELLITUS; DISEASE; GLAUCOMA, OPEN-ANGLE; HUMANS; NOREPINEPHRINE; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 70349123556     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8665.2009.00442.x     Document Type: Review

References (153)

1. ABDEL-ZAHER, A.O., AHMED, I.T. EL-KOUSSI, A.D. (2001). The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists. Pharmacol. Res., 44, 397 409.
2. ADEGHATE, E., PONERY, A.S. SHEEN, R. (2001). Streptozotocin-induced diabetes mellitus is associated with increased pancreatic tissue levels of noradrenaline and adrenaline in the rat. Pancreas, 22, 311 316.
3. AHMED, F.A., HEGAZY, K., CHAUDHARY, P. SHARMA, S.C. (2001). Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure. Brain Res., 913, 133 139.
4. AKINCI, A., CETINKAYA, E., AYCAN, Z. ONER, O. (2007). Relationship between intraocular pressure and obesity in children. J. Glaucoma, 16, 627 630.
5. ANSAH, O.B. PERTOVAARA, A. (2007). Peripheral suppression of arthritic pain by intraarticular fadolmidine, an alpha 2-adrenoceptor agonist, in the rat. Anesth. Analg., 105, 245 250.
6. ARONOW, W.S. (2008). Hypertension and the older diabetic. Clin. Geriatr. Med., 24, 489 501. vi-vii.
7. BARNES, P.J., IND, P.W. BROWN, M.J. (1982). Plasma histamine and catecholamines in stable asthmatic subjects. Clin. Sci. (Lond), 62, 661 665.
8. BELHOULA, M., CIEBIERA, J.P., DE LA CHAPELLE, A., BOISSEAU, N., COEURVEILLE, D. RAUCOULES-AIME, M. (2003). Clonidine premedication improves metabolic control in type 2 diabetic patients during ophthalmic surgery. Br. J. Anaesth., 90, 434 439.
9. BEN-NOUN, L. (2001). Characteristics of comorbidity in adult asthma. Public Health Rev., 29, 49 61.
10. BIRD, H. BROGGINI, M. (2000). Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. J. Rheumatol., 27, 2791 2797.
11. BLOOMBERG, G.R. CHEN, E. (2005). The relationship of psychologic stress with childhood asthma. Immunol Allergy Clin. North Am., 25, 83 105.
12. BOLLYKY, J., SANDA, S. GREENBAUM, C.J. (2008). Type 1 diabetes mellitus: primary, secondary, and tertiary prevention. Mt Sinai J. Med., 75, 385 397.
13. BOND, R.A., SPINA, D., PARRA, S. PAGE, C.P. (2007). Getting to the heart of asthma: can "beta blockers" be useful to treat asthma? Pharmacol. Ther., 115, 360 374.
14. BONISCH, H. BRUSS, M. (2006). The norepinephrine transporter in physiology and disease. Hand Exp. Pharmacol., 175, 485 524.
15. BROSEN, K. (2004). Some aspects of genetic polymorphism in the biotransformation of antidepressants. Therapie, 59, 5 12.
16. BURDICK, K.E., FUNKE, B., GOLDBERG, J.F., BATES, J.A., JAEGER, J., KUCHERLAPATI, R. MALHOTRA, A.K. (2007). COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord., 9, 370 376.
17. BURKE, J., KHARLAMB, A., SHAN, T., RUNDE, E., PADILLO, E., MANLAPAZ, C. WHEELER, L. (1995). Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference. Ann. NY Acad. Sci., 763, 78 95.
18. BUTLER, S.H., WEIL-FUGAZZA, J., GODEFROY, F. BESSON, J.M. (1985). Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis. Pain, 23, 159 175.
19. CALLAERTS-VEGH, Z., EVANS, K.L., DUDEKULA, N., CUBA, D., KNOLL, B.J., CALLAERTS, P.F., GILES, H., SHARDONOFSKY, F.R. BOND, R.A. (2004). Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc. Natl Acad. Sci. USA, 101, 4948 4953.
20. CAMPFIELD, L.A. SMITH, F.J. (1983). Neural control of insulin secretion: interaction of norepinephrine and acetylcholine. Am. J. Physiol., 244, R629 R634.
21. CASSIDY, F., AHEARN, E. CARROLL, B.J. (1999). Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am. J. Psychiatry, 156, 1417 1420.
22. CAUGHEY, G.E., VITRY, A.I., GILBERT, A.L. ROUGHEAD, E.E. (2008). Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health, 8, 221.
23. CHADWICK, W., WILSON, G., van de VENTER, M., OELOFSEN, W. ROUX, S. (2007). Shifts in metabolic parameters surrounding glucose homoeostasis resulting from tricyclic antidepressant therapy: implications of insulin resistance? J. Pharm. Pharmacol., 59, 95 103.
24. CHEER, S.M. GOA, K.L. (2001). Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. Drugs, 61, 81 110.
25. CHEN, Y.C., SHEN, Y.C., HUNG, Y.J., CHOU, C.H., YEH, C.B. PERNG, C.H. (2007). Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males. J. Affect. Disord., 103, 257 261.
26. CHEUNG, N. WONG, T.Y. (2007). Obesity and eye diseases. Surv. Ophthalmol., 52, 180 195.
27. CLARK, D.O. MUNGAI, S.M. (1997). Distribution and association of chronic disease and mobility difficulty across four body mass index categories of African-American women. Am. J. Epidemiol., 145, 865 875.
28. CLEMENT, L., KIM-SOHN, K.A., MAGNAN, C. et al. (2002). Pancreatic beta-cell alpha2A adrenoceptor and phospholipid changes in hyperlipidemic rats. Lipids, 37, 501 506.
29. CLONINGER, C.R. (1986). A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr. Dev., 4, 167 226.
30. CLONINGER, C.R. (1987). A systematic method for clinical description and classification of personality variants. A proposal. Arch. Gen. Psychiatry, 44, 573 588.
31. COMINGS, D.E., GADE-ANDAVOLU, R., GONZALEZ, N., WU, S., MUHLEMAN, D., BLAKE, H., MANN, M.B., DIETZ, G., SAUCIER, G. MACMURRAY, J.P. (2000). A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory. Clin. Genet., 58, 375 385.
32. COOPER, R.L., CONSTABLE, I.J. DAVIDSON, L. (1984). Catecholamines in aqueous humour of glaucoma patients. Aust. J. Ophthalmol., 12, 345 349.
33. CRAWLEY, J.N., HATTOX, S.E., MAAS, J.W. ROTH, R.H. (1978). 3-Methoxy-4-hydroxyphenethyleneglycol increase in plasma after stimulation of the nucleus locus coeruleus. Brain Res., 141, 380 384.
34. CRYER, P.E. (1993). Adrenaline: a physiological metabolic regulatory hormone in humans? Int. J. Obes. Relat. Metab. Disord., 17 (Suppl. 3 S43 S46.
35. CUTOLO, M. STRAUB, R.H. (2006). Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation, 13, 277 282.
36. DAS, V.A., ROBINSON, R. PAULOSE, C.S. (2006). Enhanced beta-adrenergic receptors in the brain and pancreas during pancreatic regeneration in weanling rats. Mol. Cell. Biochem., 289, 11 19.
37. DIAMOND, L. O'DONNELL, M. (1978). The effects of exogenous norepinephrine on ventilatory mechanics in the rat. J. Pharmacol. Exp. Ther., 207, 381 387.
38. DINH XUAN, A.T., MATRAN, R., REGNARD, J., VITOU, P., ADVENIER, C. LOCKHART, A. (1988). Comparative effects of rilmenidine and clonidine on bronchial responses to histamine in asthmatic subjects. Br. J. Clin. Pharmacol., 26, 703 708. (Pubitemid 19020624)
39. ERENMEMISOGLU, A., OZDOGAN, U.K., SARAYMEN, R. TUTUS, A. (1999). Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. J. Pharm. Pharmacol., 51, 741 743.
40. ERIKSSON, A.K., EKBOM, A., GRANATH, F., HILDING, A., EFENDIC, S. OSTENSON, C.G. (2008). Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabetes Med., 25, 834 842.
41. ESCALANTE, A., HAAS, R.W. del RINCON, I. (2005). Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch. Intern. Med., 165, 1624 1629.
42. FERLITO, S., INDELICATO, G., DI VINCENZO, S., DEL CAMPO, F., LA VIGNERA, A. FICHERA, C. (1985). Effect of clonidine on glucose, insulin and glucagon responses to a protein meal in type 2 diabetics. J. Endocrinol. Invest., 8, 185 187.
43. FERRELL, W.R. KHOSHBATEN, A. (1989). Adrenoceptor profile of blood vessels in the knee joint of the rabbit. J. Physiol., 414, 377 383.
44. FIGLEWICZ, D.P., BROT, M.D., McCALL, A.L. SZOT, P. (1996). Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res., 736, 54 60.
45. fitzgerald, p.j. (2009). Is norepinephrine an etiological factor in some types of cancer? Int. J. Cancer, 124, 257 263.
46. FOXWORTH, J.W., REISZ, G.R., PYSZCZYNSKI, D.R. KNUDSON, S.M. (1995). Oral clonidine in patients with asthma: no significant effect on airway reactivity. Eur. J. Clin. Pharmacol., 48, 19 22.
47. FRANK, R.G., KASHANI, J.H., PARKER, J.C., BECK, N.C., BROWNLEE-DUFFECK, M., ELLIOT, T.R., HAUT, A.E., ATWOOD, C., SMITH, E. KAY, D.R. (1988). Antidepressant analgesia in rheumatoid arthritis. J. Rheumatol., 15, 1632 1638.
48. FUDEMBERG, S.J., BATISTE, C. KATZ, L.J. (2008). Efficacy, safety, and current applications of brimonidine. Expert Opin Drug Saf, 7, 795 799.
49. FYLES, J.M., CAWTHORNE, M.A. HOWELL, S.L. (1986). The characteristics of beta-adrenergic binding sites on pancreatic islets of Langerhans. J. Endocrinol., 111, 263 270.
50. GASSER, P., STUMPFIG, D., SCHOTZAU, A., ACKERMANN-LIEBRICH, U. FLAMMER, J. (1999). Body mass index in glaucoma. J. Glaucoma, 8, 8 11.
51. GILLILAND, F.D., BERHANE, K., ISLAM, T., McCONNELL, R., GAUDERMAN, W.J., GILLILAND, S.S., AVOL, E. PETERS, J.M. (2003). Obesity and the risk of newly diagnosed asthma in school-age children. Am. J. Epidemiol., 158, 406 415.
52. GIUGLIANO, D., ACAMPORA, R., MARFELLA, R., LA MARCA, C., MARFELLA, M., NAPPO, F. D'ONOFRIO, F. (1998). Hemodynamic and metabolic effects of transdermal clonidine in patients with hypertension and non-insulin-dependent diabetes mellitus. Am. J. Hypertens., 11, 184 189.
53. GOLDRING, M.B., OTERO, M., TSUCHIMOCHI, K., IJIRI, K. LI, Y. (2008). Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann. Rheum. Dis., 67 (Suppl. 3 iii75 iii82.
54. GOMEZ, R., HUBER, J., TOMBINI, G. BARROS, H.M. (2001). Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats. Braz. J. Med. Biol. Res., 34, 57 64.
55. GOODNICK, P.J. (2001). Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann. Clin. Psychiatry, 13, 31 41.
56. GOODWIN, R.D., JACOBI, F. THEFELD, W. (2003). Mental disorders and asthma in the community. Arch. Gen. Psychiatry, 60, 1125 1130.
57. GRACE, E.M., BELLAMY, N., KASSAM, Y. BUCHANAN, W.W. (1985). Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Curr. Med. Res. Opin., 9, 426 429.
58. GREENFIELD, D.S., LIEBMANN, J.M. RITCH, R. (1997). Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment. J. Glaucoma, 6, 250 258.
59. GUERRA, S., SHERRILL, D.L., BOBADILLA, A., MARTINEZ, F.D. BARBEE, R.A. (2002). The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest, 122, 1256 1263.
60. GUILLAUSSEAU, P.J., MEAS, T., VIRALLY, M., LALOI-MICHELIN, M., MEDEAU, V. KEVORKIAN, J.P. (2008). Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab, 34 (Suppl. 2 S43 S48.
61. GUPTA, S.K., AGARWAL, R., GALPALLI, N.D., SRIVASTAVA, S., AGRAWAL, S.S. SAXENA, R. (2007). Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma. Methods Find. Exp. Clin. Pharmacol., 29, 665 671.
62. HANANIA, N.A., SINGH, S., EL-WALI, R. et al. (2008). The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm. Pharmacol. Ther., 21, 134 141.
63. HEY, J.A., GHEREZGHIHER, T. KOSS, M.C. (1985). Studies on the mechanism of clonidine-induced mydriasis in the rat. Naunyn Schmiedebergs Arch. Pharmacol., 328, 258 263.
64. HIRSCHFELD, R.M., CALABRESE, J.R., WEISSMAN, M.M. et al. (2003). Screening for bipolar disorder in the community. J. Clin. Psychiatry, 64, 53 59.
65. HOLGATE, S.T. (2009). Novel targets of therapy in asthma. Curr. Opin. Pulm. Med., 15, 63 71.
66. HOMMER, A., THYGESEN, J., FERRERAS, A., WICKSTROM, J., FRIIS, M.M., BUCHHOLZ, P. WALT, J.G. (2008). A European perspective on costs and cost effectiveness of ophthalmic combinations in the treatment of open-angle glaucoma. Eur. J. Ophthalmol., 18, 778 786.
67. HSU, W.H., LEE, P. BETTS, D.M. (1981). Xylazine-induced mydriasis in rats and its antagonism by alpha-adrenergic blocking agents. J. Vet. Pharmacol. Ther., 4, 97 101.
68. JANSSEN, J.A. TJIONG, H.L. (1991). Bronchial asthma improved after removal of a phaeochromocytoma. Eur. Respir. J., 4, 1021 1022.
69. JIMERSON, D.C., NURNBERGER, J.I., JR., POST, R.M., GERSHON, E.S. KOPIN, I.J. (1981). Plasma MHPG in rapid cyclers and healthy twins. Arch. Gen. Psychiatry, 38, 1287 1290.
70. KALUZA, G., STREMPEL, I. MAURER, H. (1996). Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients. J. Behav. Med., 19, 587 598. (Pubitemid 26425268)
71. KARAVANAKI, K., TSOKA, E., LIACOPOULOU, M., KARAYIANNI, C., PETROU, V., PIPPIDOU, E., BRISIMITZI, M., MAVRIKIOU, M., KAKLEAS, K. DACOU-VOUTETAKIS, C. (2008). Psychological stress as a factor potentially contributing to the pathogenesis of Type 1 diabetes mellitus. J. Endocrinol. Invest., 31, 406 415.
72. KAWAGUCHI, H., MASUO, K., KATSUYA, T., SUGIMOTO, K., RAKUGI, H., OGIHARA, T. TUCK, M.L. (2006). beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals. Hypertens. Res., 29, 951 959.
73. KAYSER, V., GUILBAUD, G. BESSON, J.M. (1992). Potent antinociceptive effects of clonidine systemically administered in an experimental model of clinical pain, the arthritic rat. Brain Res., 593, 7 13.
74. KIM, C.H., WALDMAN, I.D., BLAKELY, R.D. KIM, K.S. (2008). Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder. Ann. NY Acad. Sci., 1129, 256 260.
75. KNOL, M.J., DERIJKS, H.J., GEERLINGS, M.I., HEERDINK, E.R., SOUVEREIN, P.C., GORTER, K.J., GROBBEE, D.E. EGBERTS, A.C. (2008). Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiol. Drug Saf., 17, 577 586.
76. kubera, m., cyrul, w., basta-kaim, a., budziszewska, b., leskiewicz, m. holan, v. (2000). Effect of repeated desipramine and fluoxetine administration on post-adjuvant arthritis. Pol. J. Pharmacol., 52, 229 235.
77. KUIS, W., de JONG-de VOS van STEENWIJK, C., SINNEMA, G., KAVELAARS, A., PRAKKEN, B., HELDERS, P.J. HEIJNEN, C.J. (1996). The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav. Immun., 10, 387 398.
78. KULLOWATZ, A., ROSENFIELD, D., DAHME, B., MAGNUSSEN, H., KANNIESS, F. RITZ, T. (2008). Stress effects on lung function in asthma are mediated by changes in airway inflammation. Psychosom. Med., 70, 468 475.
79. KUPFER, C., KUWABARA, T. KAISER-KUPFER, M. (1975). The histopathology of pigmentary dispersion syndrome with glaucoma. Am. J. Ophthalmol., 80, 857 862.
80. KWOK, R.P. JUORIO, A.V. (1988). Effects of insulin on rat brain noradrenaline. Neurochem. Res., 13, 887 892.
81. LA BATIDE-ALANORE, A., CHATELLIER, G. PLOUIN, P.F. (2003). Diabetes as a marker of pheochromocytoma in hypertensive patients. J. Hypertens., 21, 1703 1707.
82. LAENGLE, U.W., COURT, M., MARKSTEIN, R., GERMANN, P.G., NOGUES, V. ROMAN, D. (2005). Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D2 receptor agonist and D1 receptor antagonist, on endotoxin-induced- uveitis and -arthritis in rats. Exp. Toxicol. Pathol., 57, 127 134. (Pubitemid 41527107)
83. LEON-QUINTO, T., MAGNAN, C. PORTHAS, B. (1998). Altered activity of the autonomous nervous system as a determinant of the impaired beta-cell secretory response after protein-energy restriction in the rat. Endocrinology, 139, 3382 3389.
84. LEVINE, J.D., CODERRE, T.J., HELMS, C. BASBAUM, A.I. (1988). Beta 2-adrenergic mechanisms in experimental arthritis. Proc. Natl Acad. Sci. USA, 85, 4553 4556.
85. LIN, E.H. (2008). Depression and osteoarthritis. Am. J. Med., 121 (11 Suppl. 2 S16 S19.
86. LIN, R., PENG, H., NGUYEN, L.P., DUDEKULA, N.B., SHARDONOFSKY, F., KNOLL, B.J., PARRA, S. BOND, R.A. (2008). Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther, 21, 115 124.
87. LINDGREN, B.R., EKSTROM, T. ANDERSSON, R.G. (1986). The effect of inhaled clonidine in patients with asthma. Am. Rev. Respir. Dis., 134, 266 269.
88. LIVNAT, S., MADDEN, K.S., FELTEN, D.L. FELTEN, S.Y. (1987). Regulation of the immune system by sympathetic neural mechanisms. Prog. Neuropsychopharmacol. Biol. Psychiatry, 11, 145 152.
89. LLOYD, P., SMITH, S.A., STRIBLING, D. POGSON, C.I. (1982). Factors affecting tryptophan-induced hypoglycaemia in rats. Biochem. Pharmacol., 31, 3563 3569. (Pubitemid 13244119)
90. LUSTMAN, P.J., GRIFFITH, L.S., CLOUSE, R.E., FREEDLAND, K.E., EISEN, S.A., RUBIN, E.H., CARNEY, R.M. McGILL, J.B. (1997). Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom. Med., 59, 241 250.
91. MABUCHI, F., YOSHIMURA, K., KASHIWAGI, K., SHIOE, K., YAMAGATA, Z., KANBA, S., IIJIMA, H. TSUKAHARA, S. (2008). High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J. Glaucoma, 17, 552 557.
92. MANNINEN, P., HELIOVAARA, M., RIIHIMAKI, H. MAKELA, P. (1997). Does psychological distress predict disability? Int. J. Epidemiol., 26, 1063 1070.
93. MARCH, L.M. BAGGA, H. (2004). Epidemiology of osteoarthritis in Australia. Med. J. Aust., 180 (5 Suppl. S6 S10.
94. MARQUIS, R.E. WHITSON, J.T. (2005). Management of glaucoma: focus on pharmacological therapy. Drugs Aging, 22, 1 21.
95. MASUO, K., KATSUYA, T., FU, Y., RAKUGI, H., OGIHARA, T. TUCK, M.L. (2005). Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation, 111, 3429 3434.
96. McELROY, S.L., FRYE, M.A., SUPPES, T. et al. (2002). Correlates of overweight and obesity in 644 patients with bipolar disorder. J. Clin. Psychiatry, 63, 207 213.
97. McINTYRE, R.S., KONARSKI, J.Z., MISENER, V.L. KENNEDY, S.H. (2005). Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann. Clin. Psychiatry, 17, 83 93.
98. MESSIER, S.P. (2008). Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management. Rheum. Dis. Clin. North Am., 34, 713 729.
99. MEYER, J.S. QUENZER, L.F. (2005). Psychopharmacology: Drugs, the Brain, and Behavior. Sinauer Associates, Inc., Sunderland, Massachusetts, 136, 397.
100. MIICHI, H. NAGATAKI, S. (1982). Effects of cholinergic drugs and adrenergic drugs on aqueous humor formation in the rabbit eye. Jpn. J. Ophthalmol., 26, 425 436.
101. MISHIMA, K., OTANI, H., TANABE, T., KAWASAKI, H., OSHIRO, A., SAITO, N., OGAWA, R. INAGAKI, C. (2001). Molecular mechanisms for alpha2-adrenoceptor- mediated regulation of synoviocyte populations. Jpn. J. Pharmacol., 85, 214 226.
102. MORS, O., MORTENSEN, P.B. EWALD, H. (1999). A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr. Res., 40, 67 74.
103. MUKHERJEE, A. WASSERMAN, M.A. (1986). Role of alpha-adrenergic receptors in cartilaginous and non-cartilaginous human airways. Methods Find. Exp. Clin. Pharmacol., 8, 667 673.
104. NAJAFIPOUR, H. FERRELL, W.R. (1993). Sympathetic innervation and beta-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint. Exp. Physiol., 78, 625 637. (Pubitemid 23282856)
105. NAJAFIPOUR, H. NIAZMAND, S. (2006). Alteration in alpha- and beta- adrenoceptor profile of rabbit-knee-joint blood vessels due to chronic inflammation. Pflugers Arch., 453, 23 32.
106. NAKADATE, T., NAKAKI, T., YAMAMOTO, S. KATO, R. (1983). Protection against alloxan-induced diabetes in mice by stimulation of alpha 2-adrenergic receptors. Life Sci., 32, 697 702.
107. NELSON, H.S., WEISS, S.T., BLEECKER, E.R., YANCEY, S.W., DORINSKY, P.M. SMART Study Group. (2006). The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest, 129, 15 26.
108. NGUYEN, L.P., OMOLUABI, O., PARRA, S. et al. (2008). Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am. J. Respir. Cell Mol. Biol., 38, 256 262.
109. NGUYEN, L.P., LIN, R., PARRA, S., OMOLUABI, O., HANANIA, N.A., TUVIM, M.J., KNOLL, B.J., DICKEY, B.F. BOND, R.A. (2009). Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc. Natl Acad. Sci. USA, 106, 2435 2440.
110. NISHIKAWA, M., DIKSIC, M., SAKAI, Y., KUMANO, H., CHARNEY, D., PALACIOS-BOIX, J., NEGRETE, J. GILL, K. (2009). Alterations in brain serotonin synthesis in male alcoholics measured using positron emission tomography. Alcohol. Clin. Exp. Res., 33, 233 239.
111. NISHIZAWA, S., BENKELFAT, C., YOUNG, S.N., LEYTON, M., MZENGEZA, S., de MONTIGNY, C., BLIER, P. DIKSIC, M. (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl Acad. Sci. USA, 94, 5308 5313.
112. NORBERG, M., STENLUND, H., LINDAHL, B., ANDERSSON, C., ERIKSSON, J.W. WEINEHALL, L. (2007). Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women. Diabetes Res. Clin. Pract., 76, 368 377.
113. O'BYRNE, S. FEELY, J. (1990). Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part I). Drugs, 40, 6 18. (Pubitemid 20230605)
114. OH, S.W., LEE, S., PARK, C. KIM, D.J. (2005). Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab. Res. Rev., 21, 434 440.
115. OKAMURA, T., FUJIOKA, H. AYAJIKI, K. (2002). Effects of nipradilol on alpha-adrenoceptor function in ocular arteries. Pharmacology, 65, 110 118.
116. PANOULAS, V.F., DOUGLAS, K.M., MILIONIS, H.J., STAVROPOULOS-KALINGLOU, A., NIGHTINGALE, P., KITA, M.D., TSELIOS, A.L., METSIOS, G.S., ELISAF, M.S. KITAS, G.D. (2007). Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford), 46, 1477 1482.
117. PATEL, K.P., ZHANG, K., HEIN, M. MAYHAN, W.G. (1997). Peripheral noradrenergic turnover in streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract., 35, 1 9.
118. PERNET, A., WALKER, M., GILL, G.V., ORSKOV, H., ALBERTI, K.G. JOHNSTON, D.G. (1984). Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin. Diabetes Metab., 10, 98 105.
119. REMINGTON, T.L. DIGIOVINE, B. (2005). Long-acting beta-agonists: anti-inflammatory properties and synergy with corticosteroids in asthma. Curr. Opin. Pulm. Med., 11, 74 78.
120. del REY, A., WOLFF, C., WILDMANN, J., RANDOLF, A., HAHNEL, A., BESEDOVSKY, H.O. STRAUB, R.H. (2008). Disrupted brain-immune system-joint communication during experimental arthritis. Arthritis Rheum., 58, 3090 3099.
121. RITTENHOUSE, K.D. POLLACK, G.M. (2000). Pharmacodynamics of beta-blocker modulation of aqueous humor production. Exp. Eye Res., 70, 429 439.
122. RODRIGUES, L.L., OLIVEIRA, M.C., PELEGRINI-da-SILVA, A., de ARRUDA VEIGA, M.C., PARADA, C.A. TAMBELI, C.H. (2006). Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J. Pain, 7, 929 936.
123. ROUMESTAN, C., MICHEL, A., BICHON, F., PORTET, K., DETOC, M., HENRIQUET, C., JAFFUEL, D. MATHIEU, M. (2007). Anti-inflammatory properties of desipramine and fluoxetine. Respir. Res., 8, 35.
124. SAVONTAUS, E., FAGERHOLM, V., RAHKONEN, O. SCHEININ, M. (2008). Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha(2A)-adrenoceptor knockout mice. Eur. J. Pharmacol., 578, 359 364.
125. SCHELLEVIS, F.G., van der VELDEN, J., van de LISDONK, E., van EIJK, J.T. van WEEL, C. (1993). Comorbidity of chronic diseases in general practice. J. Clin. Epidemiol., 46, 469 473. (Pubitemid 23194269)
126. SCHETT, G. (2009). Osteoimmunology in rheumatic diseases. Arthritis Res. Ther., 11, 210.
127. SCHILDKRAUT, J.J. (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry, 122, 509 522.
128. SCHLINDWEIN, P., BUCHHOLZ, H.G., SCHRECKENBERGER, M., BARTENSTEIN, P., DIETERICH, M. BIRKLEIN, F. (2008). Sympathetic activity at rest and motor brain areas: FDG-PET study. Auton. Neurosci., 143, 27 32.
129. SCOTT, G.C., CHU, C.S. BRAUN, S.R. (1991). Transdermal delivery of the alpha 2-agonist clonidine does not alter airways responses to inhaled histamine or methacholine. Chest, 100, 1035 1038.
130. SEKI, M., TANAKA, T., MATSUDA, H., TOGANO, T., HASHIMOTO, K., UEDA, J., FUKUCHI, T. ABE, H. (2005). Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model. Br. J. Ophthalmol., 89, 504 507.
131. SICA, D.A. (2007). Centrally acting antihypertensive agents: an update. J. Clin. Hypertens. (Greenwich), 9, 399 405.
132. SIPETIC, S., VLAJINAC, H., MARINKOVI, J., KOCEV, N., MILAN, B., RATKOV, I. SAJIC, S. (2007). Stressful life events and psychological dysfunctions before the onset of type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab., 20, 527 534.
133. SKOGLUND, G., LUNDQUIST, I. AHREN, B. (1986). Effects of alpha 1- and alpha 2-adrenoceptor stimulation and blockade on plasma insulin levels in the mouse. Pancreas, 1, 415 420.
134. SOLT, V.B., BROWN, M.R., KENNEDY, B., KOLTERMAN, O.G. ZIEGLER, M.G. (1990). Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am. J. Hypertens., 3, 823 828.
135. SUBRAMANIAN, S.V., ACKERSON, L.K., SUBRAMANYAM, M.A. WRIGHT, R.J. (2007). Domestic violence is associated with adult and childhood asthma prevalence in India. Int. J. Epidemiol., 36, 569 579.
136. SZELENYI, J. VIZI, E.S. (2007). The catecholamine cytokine balance: interaction between the brain and the immune system. Ann. N Y Acad. Sci., 1113, 311 324.
137. TAYLOR, D.R. (2007). beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications. Expert Opin. Pharmacother., 8, 3195 3203.
138. TOYOTA, T., SATO, S.I., KUDO, M., ABE, K. GOTO, Y. (1975). Secretory regulation of endocrine pancreas: Cyclic AMP and glucagon secretion. J. Clin. Endocrinol. Metab., 41, 81 89.
139. TURYK, M.E., HERNANDEZ, E., WRIGHT, R.J., FREELS, S., SLEZAK, J., CONTRARAS, A., PIORKOWSKI, J. PERSKY, V.W. (2008). Stressful life events and asthma in adolescents. Pediatr. Allergy Immunol., 19, 255 263.
140. VIEIRA, E., LIU, Y.J. GYLFE, E. (2004). Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell. Naunyn Schmiedebergs Arch. Pharmacol., 369, 179 183.
141. VIG, R.S., FORSYTHE, P. VLIAGOFTIS, H. (2006). The role of stress in asthma: insight from studies on the effect of acute and chronic stressors in models of airway inflammation. Ann. NY Acad. Sci., 1088, 65 77.
142. VLCEK, M., ROVENSKY, J., BLAZICEK, P., RADIKOVA, Z., PENESOVA, A., KERLIK, J., KVETNANSKY, R. IMRICH, R. (2008). Sympathetic nervous system response to orthostatic stress in female patients with rheumatoid arthritis. Ann. NY Acad. Sci., 1148, 556 561.
143. WAHLE, M., HANEFELD, G., BRUNN, S., STRAUB, R.H., WAGNER, U., KRAUSE, A., HÄNTZSCHEL, H. BAERWALD, C.G. (2006). Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis. Arthritis Res. Ther., 8, R138.
144. WALSH, G.M. (2008). Emerging drugs for asthma. Expert Opin. Emerg. Drugs, 13, 643 653.
145. WEBER-HAMANN, B., GILLES, M., LEDERBOGEN, F., HEUSER, I. DEUSCHLE, M. (2006). Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. J. Clin. Psychiatry, 67, 1856 1861.
146. WEBERS, C.A., BECKERS, H.J., NUIJTS, R.M. SCHOUTEN, J.S. (2008). Pharmacological management of primary open-angle glaucoma: second-line options and beyond. Drugs Aging, 25, 729 759.
147. WEINBERGER, M., TIERNEY, W.M., BOOHER, P. HINER, S.L. (1990). Social support, stress and functional status in patients with osteoarthritis. Soc. Sci. Med., 30, 503 508.
148. WERBEL, S.S. OBER, K.P. (1995). Pheochromocytoma. Update on diagnosis, localization, and management. Med. Clin. North Am., 79, 131 153.
149. WHEELER, L.A. WOLDEMUSSIE, E. (2001). Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma. Eur. J. Ophthalmol., 11 (Suppl. 2 S30 S35.
150. WIESNER, T.D., BLUHER, M., WINDGASSEN, M. PASCHKE, R. (2003). Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J. Clin. Endocrinol. Metab., 88, 3632 3636.
151. YAMAMOTO, K., SAKAMOTO, Y., IRIE, M., OHMORI, S., YOSHINARI, M. KACANIKU, G. (2008). The relationship between IMPS-measured stress score and intraocular pressure among public school workers. J. Physiol. Anthropol., 27, 43 50.
152. ZAUTRA, A.J. SMITH, B.W. (2001). Depression and reactivity to stress in older women with rheumatoid arthritis and osteoarthritis. Psychosom. Med., 63, 687 696.
153. ZAUTRA, A.J., BURLESON, M.H., MATT, K.S., ROTH, S. BURROWS, L. (1994). Interpersonal stress, depression, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol., 13, 139 148.